By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Affymetrix's fourth-quarter revenues fell 23 percent year over year, missing analysts' estimates, the company reported after the close of the market on Wednesday.

For the quarter ended Dec. 31, 2011, the Santa Clara, Calif.-based microarray firm said that it posted $65.1 million in revenues, down from $84.9 million a year ago, and short of Wall Street expectations of $65.6 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.